SWAP70 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.434000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.166800E-01
Normal-vs-Stage2
3.553800E-01
Normal-vs-Stage3
3.086000E-01
Normal-vs-Stage4
3.905800E-01
Stage1-vs-Stage2
5.039000E-01
Stage1-vs-Stage3
8.788000E-01
Stage1-vs-Stage4
2.934600E-01
Stage2-vs-Stage3
5.039000E-01
Stage2-vs-Stage4
7.202000E-01
Stage3-vs-Stage4
2.570600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.400800E-01
Normal-vs-AfricanAmerican
3.355800E-01
Normal-vs-Asian
2.814800E-01
Caucasian-vs-AfricanAmerican
3.447600E-01
Caucasian-vs-Asian
1.373430E-01
AfricanAmerican-vs-Asian
1.672390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.371000E-01
Normal-vs-Female
3.523800E-01
Male-vs-Female
5.206400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.664800E-01
Normal-vs-Age(41-60Yrs)
3.989600E-01
Normal-vs-Age(61-80Yrs)
3.230400E-01
Normal-vs-Age(81-100Yrs)
3.112800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.738200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.254600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.356000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.996800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.633600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.577600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.284400E-01
Normal-vs-Daily Drinker
2.962000E-01
Normal-vs-Weekly Drinker
3.030200E-01
Normal-vs-Occasional Drinker
3.454200E-01
Normal-vs-Social Drinker
3.654000E-01
Non Drinker-vs-Daily Drinker
3.494800E-01
Non Drinker-vs-Weekly Drinker
5.227000E-01
Non Drinker-vs-Occasional Drinker
7.120400E-01
Non Drinker-vs-Social Drinker
4.865200E-01
Daily Drinker-vs-Weekly Drinker
8.569800E-01
Daily Drinker-vs-Occasional Drinker
2.254800E-01
Daily Drinker-vs-Social Drinker
1.471180E-01
Weekly Drinker-vs-Occasional Drinker
3.599200E-01
Weekly Drinker-vs-Social Drinker
2.563400E-01
Occasional Drinker-vs-Social Drinker
7.483800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.306200E-01
Normal-vs-Grade 2
1.298420E-01
Normal-vs-Grade 3
1.189830E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.233600E-01
Grade 1-vs-Grade 3
3.902400E-01
Grade 1-vs-Grade 4
5.306200E-01
Grade 2-vs-Grade 3
5.358600E-01
Grade 2-vs-Grade 4
1.298420E-01
Grade 3-vs-Grade 4
1.189830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.592800E-01
Normal-vs-NonDiabetic
3.176200E-01
Diabetic-vs-NonDiabetic
1.346760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.125200E-01
Normal-vs-NoPancreatitis
3.337200E-01
Pancreatitis-vs-NoPancreatitis
3.991600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.312600E-01
Normal-vs-N1
3.540400E-01
N0-vs-N1
3.636000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.668200E-01
Normal-vs-TP53-NonMutant
3.143600E-01
TP53-Mutant-vs-TP53-NonMutant
1.256560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
